Literature DB >> 18663307

Maggots do not survive in pyoderma gangrenosum.

Regina Renner1, Regina Treudler, Jan C Simon.   

Abstract

Application of maggots is well established in wound therapy. We report upon 2 patients with leg ulcers due to pyoderma gangrenosum who received immunosuppressive therapy and in whom a reduced survival of maggots (Lucilia sericata sp.) led to ineffectiveness of this therapy. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh：

Year:  2008        PMID： 18663307     DOI： 10.1159/000148251

Source DB:  PubMed          Journal:  Dermatology        ISSN： 1018-8665            Impact factor:   5.366


  6 in total

Review 1.  [Biosurgical débridement using Lucilia sericata-maggots - an update].

Authors:  Pietro Nenoff; Antonia Herrmann; Christina Gerlach; Jürgen Herrmann; Jan Christoph Simon
Journal:  Wien Med Wochenschr       Date:  2010-08-16

Review 2.  Management of pyoderma gangrenosum.

Authors:  Alexandra Teagle; Rachel Hargest
Journal:  J R Soc Med       Date:  2014-06-09       Impact factor: 5.344

3.  Maggot debridement: an alternative method for debridement.

Authors:  Finn Gottrup; Bo Jørgensen
Journal:  Eplasty       Date:  2011-07-12

4.  Quorum-sensing-regulated virulence factors in Pseudomonas aeruginosa are toxic to Lucilia sericata maggots.

Authors:  A S Andersen; B Joergensen; T Bjarnsholt; H Johansen; T Karlsmark; M Givskov; K A Krogfelt
Journal:  Microbiology (Reading)       Date:  2009-11-05       Impact factor: 2.777

5.  Growth and Survival of Bagged Lucilia sericata Maggots in Wounds of Patients Undergoing Maggot Debridement Therapy.

Authors:  Helena Cičková; Marek Cambal; Milan Kozánek; Peter Takáč
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-25       Impact factor: 2.629

6.  Two cases of maggot debridement therapy in pyoderma gangrenosum.

Authors:  Ryan S Din; William G Tsiaras; Arash Mostaghimi
Journal:  JAAD Case Rep       Date:  2018-11-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.